Numerous studies have demonstrated that KIF23 mRNA and/or protein is overexpressed in NSCLC and SCLC tumours, which are associated with poor prognosis of patients, specifically greater tumour stage, and worse overall and recurrence-free survival [103,104,105,106,107,108,109,110]. Here, KIF23 is linked to non-small cell lung carcinoma.